A systematic and structured assessment is essential for the evaluation of olfactory dysfunction in children. The first step involves a comprehensive clinical history, focusing on the onset, duration, and progression of olfactory loss. Establishing whether the deficit is congenital or acquired, transient or persistent, stable, or progressive, provides critical information for narrowing the differential diagnosis and guiding further investigations (Figure 1).

A wide range of predisposing factors should be considered. Among congenital conditions, clinicians should be aware of syndromic disorders such as Kallmann syndrome, characterized by hypogonadotropic hypogonadism and anosmia, and CHARGE syndrome, in which primary olfactory bulb defects may contribute to dysfunction (5). Additional congenital causes include Turner syndrome, Bardet-Biedl syndrome, where impaired ciliary function disrupts olfactory sensory neurons (6), and cleft palate, where anatomical, genetic, or neurological factors can compromise olfaction (7).

Acquired causes are also highly relevant in pediatric populations and include post-viral infections, particularly Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which may induce temporary or persistent olfactory loss, head trauma or intracranial masses (benign or malignant) affecting olfactory pathways. Structural nasal conditions such as adenoid hypertrophy should be acknowledged, with evidence suggesting recovery of olfactory function following adenoidectomy (8, 9). Other acquired factors include nasal polyps, especially in children with cystic fibrosis, and allergic rhinitis, where disease severity may correlate with olfactory impairment (10). Iatrogenic causes, such as previous endoscopic endonasal surgery, can induce hyposmia, which may be transient or persistent (11). Finally, systemic diseases (e.g., hypothyroidism, other hormonal disorders) and neurological diseases, including autism spectrum disorders (ASD) (12), as well as exposure to medications or environmental toxins, should also be evaluated.

Generally, congenital and post-traumatic causes are more prevalent in younger children. As age increases, these etiologies are progressively replaced by post-infectious and idiopathic causes (3).

In addition to identifying predisposing factors, clinicians should document associated symptoms such as nasal congestion or obstruction, and any neurological deficits, which may indicate central involvement of the olfactory pathways. A detailed family history is equally important, as hereditary olfactory dysfunction—including congenital anosmia or syndromic forms—can provide important diagnostic clues and suggest a genetic predisposition.

The ENT clinical examination should be comprehensive. First, any craniofacial deformities or anomalies must be documented and considered. Examination includes inspection of the oral cavity and anterior rhinoscopy, which allows primary assessment of inferior turbinate hypertrophy, the presence of nasal secretions (e.g., serous or mucous), and visible nasal polyps. For a more detailed evaluation, both flexible and rigid nasal endoscopy can be performed. Flexible endoscopy enables exploration of all meatuses (inferior, middle, and superior), assessment of anatomical anomalies of the middle turbinate, and detection of obstructions in the nasopharynx, such as adenoid hypertrophy or choanal atresia (13). The olfactory region can also be examined for potential obstruction. Nasal polyps can be classified using standardized scoring systems, the most commonly applied being the Nasal Polyp Score (14). Finally, in patients who have undergone prior surgery, endoscopy allows assessment of surgical outcomes, including synechiae, anatomical changes, and recurrence of pathology.

The next step in the diagnostic process involves structured olfactory testing, integrating psychophysical, subjective, and age-appropriate assessments to accurately characterize olfactory function in children. The absence of standardized diagnostic protocols for children represents a significant barrier to the early identification and management of OD. This lack of clear guidelines limits opportunities for effective screening and contributes to delayed diagnosis, potentially compromising timely treatment and recovery (15). A concise overview of validated olfactory assessment tools currently available for pediatric populations is provided in Table 1.

Psychophysical assessment represents a cornerstone in the evaluation of pediatric OD and enables comparisons across age groups and clinical conditions. Among the standardized and validated tools, the Sniffin’ Sticks Test (SSIT) (16), provides a composite Threshold–Discrimination–Identification (TDI) score, while the University of Pennsylvania Smell Identification Test (UPSIT) (17), is an identification-only test that quantifies the ability to recognize specific odors from multiple-choice options.

The SSIT remains one of the most used and validated tools in the world for both adults and children. Because odor identification is heavily influenced by familiarity and cultural background, these tests have been translated and culturally adapted into multiple languages to preserve diagnostic reliability. The Pediatric Sniffin’ Stick test has shown good feasibility and reliability in children over 6 years of age, although normative data remain limited and cross-cultural validation is ongoing (18, 19).

Recent literature (20) recommends several tests for valid and reliable olfactory assessment in children. These include the Universal Sniff Odor Identification Test (U-Sniff) which consist of 12 odor pens with picture-based multiple-choice identification (21); the National Institutes of Health Toolbox (NIH-TB) which uses six familiar odors for children, requiring identification among distractors and providing valid, age-appropriate olfactory assessment (22); the Pediatric Barcelona Olfactory Test-6 (pBOT-6) which combines six odorants for forced-choice identification and a six-dilution phenyl ethyl alcohol series for threshold testing (23) and the Pediatric Smell Wheel, designed with simplified odor sets and visual cues to enhance engagement and comprehension while reducing fatigue in early developmental stages (24, 25).

In addition to psychophysical testing, subjective assessments play a complementary role. Self-reported measures, pediatric-adapted questionnaires, and parental observations can capture the child's perception of smell-related difficulties, behavioral changes, and quality-of-life impact—especially when formal testing is limited by age, attention span, or comprehension.

Despite these advances, olfactory testing in children remains methodologically challenging. Younger patients may display reduced motivation, difficulty understanding instructions, or unfamiliarity with specific odors, potentially leading to variable results. Beyond psychophysical methods, electrophysiological techniques—such as olfactory event-related potentials (OERPs)—offer objective insights into olfactory pathway function, but pediatric applications remain limited (26).

These diagnostic tools provide a standardized framework for evaluating olfactory capacity in children. Moreover, retronasal olfactory tests may offer additional diagnostic insights, as adenoid hypertrophy—a common condition in childhood—appears to impair retronasal olfaction more prominently than orthonasal function (27). In clinical practice, children undergoing adenoidectomy are often reported to eat more varied foods than before surgery, which clinicians attribute to an improvement in retronasal olfaction. However, the test proposed by Colbert et al. (27), which involves sampling solutions containing either taste or odor compounds, should be introduced into clinical practice to objectively assess retronasal olfaction. Comparing test results before and after surgery could demonstrate the benefit of adenoidectomy in improving olfactory function.

Neuroimaging plays a key role in the diagnostic evaluation of OD in selected pediatric cases. In recent years, the use of magnetic resonance imaging (MRI) has significantly advanced the radiological assessment of the olfactory system. MRI allows high-resolution visualization of the olfactory bulbs (OB), olfactory tracts (OT), and adjacent forebrain structures that may be implicated in both congenital and acquired forms of olfactory dysfunction. Moreover, functional MRI (fMRI) contributes to the identification of structural and functional abnormalities, including hypoplasia or aplasia of the OB, providing valuable insights into the neuroanatomical correlates of olfactory loss.

Several studies have demonstrated a strong correlation between OB volume and olfactory function, with patients affected by OD showing significantly smaller bulbs compared to healthy controls (28–31). MRI also facilitates the detection and differentiation of intracranial masses or space-occupying lesions that may contribute to secondary olfactory impairment. One of the major advantages of MRI in pediatric populations is the absence of ionizing radiation, making it particularly suitable for repeated or follow-up imaging in children.

Conversely, a computed tomography (CT) scan remains the preferred imaging modality when bony or sinonasal abnormalities are suspected. CT provides excellent definition of the bony structures of the nasal cavity and paranasal sinuses, enabling accurate evaluation of traumatic injuries, anatomical deformities, and iatrogenic changes. Therefore, MRI and CT should be regarded as complementary techniques, each providing distinct but synergistic diagnostic information in the assessment of pediatric olfactory disorders.

Beyond radiological imaging, neurological evaluation can help identify associated central nervous system abnormalities or neurodevelopmental disorders that may contribute to OD. When a systemic or endocrine disease is suspected—such as hormonal dysfunction or metabolic disorders—collaboration with an endocrinologist is recommended to ensure a comprehensive diagnostic framework. In cases of congenital olfactory disorders, genetic assessment is fundamental to confirm the diagnosis and guide appropriate counseling for patients and families. Finally, close cooperation with maxillofacial surgeons is often necessary for the evaluation and correction of craniofacial or bony anomalies that may underline or exacerbate olfactory impairment.

The pediatrician plays a central role in this multidisciplinary network, acting as the primary coordinator who integrates clinical information, guides referrals, and ensures continuity of care among the various specialists involved. Integrating these disciplines ensures a holistic diagnostic framework, improving etiological accuracy and guiding personalized treatment strategies. Therefore, a multidisciplinary approach is essential for the accurate assessment and effective management of OD in children.

The management of pediatric OD depends on the underlying etiology and can be broadly categorized into treatable and non-treatable conditions. Identifying the root cause is essential to guide targeted therapy and optimize functional recovery (Figure 2).

Among treatable causes, obstructive and structural disorders are particularly relevant. Surgical interventions can restore nasal patency and improve olfactory function. Common procedures include adenoidectomy for adenoid hypertrophy, Functional Endoscopic Sinus Surgery (FESS) for nasal polyps, and turbinoplasty for turbinate hypertrophy (32). Surgical management may also be indicated for nasal or intracranial masses, with the approach tailored according to benign or malignant pathology.

Infectious and inflammatory conditions are typically managed with medical therapy (e.g., antibiotics, corticosteroids), both in acute and chronic rhinosinusitis. However, in selected chronic cases, surgical intervention may be necessary. Intranasal corticosteroids have demonstrated efficacy not only in sinonasal diseases such as nasal polyposis, but also in post-viral inflammatory anosmia, reducing local inflammation and improving olfactory function (33). According to some published protocols, the treatment may include budesonide irrigations once daily by adding 0.5 mg/2.0 mL of budesonide into a 200 mL saline sinus irrigation bottle (34). In recent years, biologic therapies have expanded treatment options for related conditions. Although biologics are not formally approved for pediatric chronic rhinosinusitis with nasal polyps (CRSwNP), they may be considered in children who meet criteria for other approved indications, such as severe asthma, atopic dermatitis, or eosinophilic disorders (35–37).

In case of untreatable diseases, including congenital syndromes (e.g., Kallmann syndrome, olfactory bulb hypoplasia/aplasia), management focuses on supportive care, olfactory training, and addressing psychosocial consequences. Olfactory training (OT), consisting of daily exposure to a set of specific odors, has been shown to stimulate functional recovery, particularly in post-infectious or post-traumatic OD (38). In pediatric settings, children are typically encouraged to practice daily with a limited set of familiar scents, chosen to maintain motivation and adherence. The selection of odors can be individualized rather than standardized, and training is often supported by parental supervision or the use of a simple diary to document adherence (34).

Ultimately, effective management requires a multimodal approach, integrating surgical, medical, and rehabilitative strategies while considering the child's overall development and quality of life. Tailoring therapy to the underlying cause and providing supportive interventions ensures not only functional recovery but also addresses the emotional and social impact of olfactory loss.

Once the underlying causes have been identified and appropriate treatment has been initiated, follow-up is essential to monitor the course and progression of pediatric OD. Clinical monitoring should include repeat olfactory testing and comprehensive ENT evaluations at regular intervals, typically every 6–12 months. These assessments provide psychophysical information on olfactory function, including threshold, discrimination, and identification performance, and enable the early detection of deterioration or improvement, particularly in cases of post-infectious, post-traumatic, or surgically treated OD.

Regular follow-up also allows for the evaluation of associated nasal or systemic conditions, including recurrent sinus infections, allergic rhinitis, or structural changes following surgery. In children receiving medical therapy, such as intranasal corticosteroids or biologics, repeated assessments can help determine treatment efficacy and guide adjustments in dosage or therapeutic approach. Similarly, in patients undergoing olfactory training, periodic evaluations provide feedback on adherence, performance, and potential benefits, supporting optimization of the rehabilitation program.

Family education represents an equally important aspect of follow-up care. Children with OD are at increased risk for environmental hazards, including gas leaks, smoke, spoiled food, or fire. Parents and caregivers should be counseled on safety measures and strategies to mitigate these risks. Additionally, guidance on dietary adaptations, olfactory cues for daily activities, and psychosocial support can improve quality of life and foster independence, particularly in younger children.

A structured follow-up protocol, combining objective olfactory testing, clinical reassessment, and family education, ensures a holistic approach to pediatric OD. It allows clinicians to track the course of the disorder, tailor interventions over time, and provide families with the knowledge and resources necessary to manage the functional and safety challenges associated with olfactory loss. By integrating clinical, rehabilitative, and educational strategies, follow-up care supports both recovery and long-term adaptation, addressing the multifaceted impact of OD in childhood.

This review has several limitations. Being narrative in nature, it does not follow a systematic review methodology and may therefore be subject to selection bias. The available literature on pediatric OD is sparse and heterogeneous, often based on small cohorts or extrapolated from adult data. Diagnostic and therapeutic recommendations are therefore largely based on expert opinion rather than high-level evidence. Moreover, psychophysical tests validated in adults are only partially adapted for children, limiting comparability across studies. Finally, cultural and linguistic differences further challenge the interpretation of olfactory test results and the generalizability of findings.

Despite these limitations, the proposed approach provides a pragmatic and multidisciplinary framework that may assist clinicians in structuring diagnostic reasoning, improving etiological accuracy, and raising awareness of the significance of olfactory loss in children. Future multicenter and longitudinal studies are needed to clarify the pathophysiological links between allergic airway inflammation and smell impairment, to validate pediatric-specific diagnostic tools, and to assess the efficacy of medical and rehabilitative interventions.